SMO ClinPlus CO.,LTD. (SHE:301257)

SMO ClinPlus CO.,LTD. Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Operating Revenue	795.66	803.73	760.04	586.23	502.97	335.29
Other Revenue	-	-	0	0	-	-
Revenue	795.66	803.73	760.04	586.23	502.97	335.29
Revenue Growth (YoY)	1.05%	5.75%	29.65%	16.55%	50.01%	10.46%
Cost of Revenue	617.77	607.75	528.94	426.25	371.77	237.64
Gross Profit	177.89	195.98	231.1	159.98	131.19	97.65
Selling, General & Admin	50.94	52.37	50.28	49.86	33.74	39.5
Research & Development	36.23	35.84	34.75	32.23	21.19	14.99
Other Operating Expenses	5.27	5.29	5.18	2.99	2.94	1.08
Operating Expenses	101.95	102.54	100.58	91.25	63.71	59.57
Operating Income	75.95	93.44	130.52	68.73	67.49	38.08
Interest Expense	-0.38	-0.44	-0.32	-0.18	-0.27	-
Interest & Investment Income	14.61	16.35	16.44	6.82	1.73	0.56
Earnings From Equity Investments	-	-	-	-	-	-1.75
Other Non Operating Income (Expenses)	-0.76	-0.77	-0.48	0.19	-0.52	-0.15
EBT Excluding Unusual Items	89.41	108.58	146.16	75.56	68.42	36.74
Gain (Loss) on Sale of Investments	0.64	0.58	1.14	0.84	-1.47	-
Gain (Loss) on Sale of Assets	-0.13	-0.12	0.02	0.02	-0.08	-0.05
Asset Writedown	0.34	-	-0.01	-0	-0	-0
Other Unusual Items	12.61	12.54	13.72	4.41	-	4.83
Pretax Income	102.87	121.58	161.03	80.84	66.88	41.51
Income Tax Expense	11.75	15.15	26.3	8.43	9.11	6.19
Net Income	91.12	106.43	134.73	72.41	57.77	35.32
Net Income to Common	91.12	106.43	134.73	72.41	57.77	35.32
Net Income Growth	-31.04%	-21.00%	86.06%	25.35%	63.58%	-32.55%
Shares Outstanding (Basic)	85	79	78	70	59	59
Shares Outstanding (Diluted)	85	79	79	71	59	59
Shares Change (YoY)	14.69%	0.06%	11.32%	20.98%	-	-
EPS (Basic)	1.08	1.35	1.72	1.04	0.99	0.60
EPS (Diluted)	1.08	1.35	1.71	1.02	0.98	0.60
EPS Growth	-39.87%	-21.05%	67.14%	3.91%	63.09%	-32.34%
Free Cash Flow	-34.99	-10.29	104.6	32.48	37.11	18.36
Free Cash Flow Per Share	-0.41	-0.13	1.33	0.46	0.63	0.31
Dividend Per Share	0.250	0.250	0.180	0.083	-	-
Dividend Growth	38.89%	38.89%	116.61%	-	-	-
Gross Margin	22.36%	24.38%	30.41%	27.29%	26.08%	29.12%
Operating Margin	9.54%	11.63%	17.17%	11.72%	13.42%	11.36%
Profit Margin	11.45%	13.24%	17.73%	12.35%	11.49%	10.53%
Free Cash Flow Margin	-4.40%	-1.28%	13.76%	5.54%	7.38%	5.48%
EBITDA	81.5	98.79	135.08	72.29	70.3	40.33
EBITDA Margin	10.24%	12.29%	17.77%	12.33%	13.98%	12.03%
D&A For EBITDA	5.55	5.35	4.55	3.56	2.81	2.25
EBIT	75.95	93.44	130.52	68.73	67.49	38.08
EBIT Margin	9.54%	11.63%	17.17%	11.72%	13.42%	11.36%
Effective Tax Rate	11.42%	12.46%	16.33%	10.42%	13.62%	14.92%
Revenue as Reported	795.66	803.73	760.04	586.23	502.97	335.29

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.